Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Outstanding Warrants

<< Previous

Bullboard Posts

Next >>

Comment by LouisWon Nov 14, 2022 8:06pm

107 Views

Post# 35098436

RE:RE:RE:RE:RE:RE:Outstanding Warrants

Taimed owned 2369582 shares in 2022Q2. Actually, they discussed if they need to sell some shares of TH on anual board meeting, but i dont know what the decision was.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (June 28, 2024)